First experience with direct, selective factor Xa inhibition in patients with non-ST-elevation acute coronary syndromes: results of the XaNADU-ACS Trial
Open Access
- 6 December 2004
- journal article
- clinical trial
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 3 (3) , 439-447
- https://doi.org/10.1111/j.1538-7836.2004.01081.x
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Subcutaneous Fondaparinux versus Intravenous Unfractionated Heparin in the Initial Treatment of Pulmonary EmbolismNew England Journal of Medicine, 2003
- Silent Myocardial IschemiaCirculation, 2003
- Secondary Prophylaxis with Warfarin for Venous ThromboembolismNew England Journal of Medicine, 2003
- First Experience With Direct Factor Xa Inhibition in Patients With Stable Coronary DiseaseCirculation, 2002
- Misreporting of myocardial infarction end points: Results of adjudication by a central clinical events committee in the PARAGON-B trialAmerican Heart Journal, 2002
- A Synthetic Pentasaccharide for the Prevention of Deep-Vein Thrombosis after Total Hip ReplacementNew England Journal of Medicine, 2001
- Low-Molecular-Weight HeparinCirculation, 1998
- Effects of Integrelin, a Platelet Glycoprotein IIb/IIIa Receptor Antagonist, in Unstable AnginaCirculation, 1996
- ST segment shift in unstable angina: pathophysiology and association with coronary anatomy and hospital outcomeJournal of the American College of Cardiology, 1989
- Silent Ischemia as a Marker for Early Unfavorable Outcomes in Patients with Unstable AnginaNew England Journal of Medicine, 1986